A nationwide longitudinal natural history study and biobank for Neurofibromatosis type 1 (NF1) established within the NF1 Expertise network in the Netherlands. The project integrates clinical, genetic, imaging, and biospecimen-related data to support research into clinical predictors and molecular biomarkers. Data collection is based on the EU-PEARL LNHS protocol and the ERN-GENTURIS registry, with genetic data aligned with the NESTOR registry.
Use Cases
- Identify clinical predictors of disease progression based on longitudinal clinical data.
- Discover molecular biomarkers for plexiform neurofibromas and malignant peripheral nerve sheath tumours based on integrated biospecimen data.
- Develop risk stratification models based on integrated clinical, genetic, and imaging data.
- Enable earlier detection of NF1 complications based on the longitudinal study design.
Strengths
- Data collection is based on standardized frameworks including the EU-PEARL LNHS protocol and ERN-GENTURIS registry, suggesting structured data capture.
- Integrates multiple data types including clinical, genetic, imaging, and biospecimen-related data.
- Includes a codebook with variable definitions, labels, and permitted values, indicating documentation.
Limitations
- Row count is unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- Description metadata is limited; actual data quality requires manual inspection after download.
Provenance
- Source
- NF1 Expertise network in the Netherlands
- Collection Method
- Nationwide longitudinal natural history study and biobank
- Freshness
- Last updated 2026-07-13 06:10:17; freshness should be verified.
- Geography
- Netherlands